Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis takes hit from private label

This article was originally published in The Tan Sheet

Executive Summary

A shift in U.S. consumer spending toward private label products stymied Novartis Consumer Healthcare's sales in its fiscal 2008 second quarter, the Swiss company says July 17. However, "emerging markets and strategic brands helped OTC offset lower sales in the U.S" so the division still pulled in $1.5 billion in net sales, a 15 percent increase in the U.S., or a 3 percent increase in local currency, compared to the year-ago period, Novartis says. Despite a tough quarter for consumer sales, net sales for the firm grew ahead of expectations to $10.7 billion - a 14 percent increase in U.S. dollars, or 5 percent in local currencies, primarily attributed to Novartis' pharmaceutical division overcoming the impact of 2007 challenges in U.S. vaccines and diagnostics, the firm says. Novartis' bad news comes as private labeler Perrigo reports expansion plans and expects a boost from consumers using less expensive store brand products (1"The Tan Sheet" July 14, 2008, p. 3)...

You may also be interested in...



Perrigo Reaches Record As Retailers, Consumers Turn More To Store Brands

Current challenging economic conditions may help Perrigo's private label business grow, unlike the sales slumps that commonly hit consumer product companies when spending slows

US Lab-Testing Certification Process Will Be Streamlined Under Quick-Start Guide, CMS Says

The US Medicare agency has released a quick-start guide for laboratory certification.

Washington State Ecology Mulls ‘Safer’ Definition While Exploring Phthalate Alternatives In Fragrances

Marissa Smith, senior regulatory toxicologist in the Washington Department of Ecology’s Hazardous Waste and Toxics Reduction program, discusses what’s next for the state’s inaugural Safer Products go-round. “How we define ‘safer’ is really going to be the lynchpin of this whole process,” she says.

Topics

UsernamePublicRestriction

Register

ID1128360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel